Advaxis To Present Poster Entitled “Natural Killer (NK) Cells Orchestrate The Antitumor Activities Of Listeria Monocytogenes (Lm)-Based Immunotherapy” At Society For Immunotherapy Of Cancer Annual Meeting

Advaxis Reports Fiscal Year 2018 Financial Results And Provides a Business Update

Data Highlighting Advaxis’ Antigen Delivery Platform Accepted For Multiple Presentations At 2018 Keystone Symposia Conference On Cancer Immunotherapies: Combinations